I will support her efforts to have a full and open hearing on the heparin issue.

I think we both have to agree that the timeline is a strong economic disincentive.

It takes chutzpah to haul the FDA Commissioner up here and grill her about why FDA is not doing more to keep the food and drug supply safe while simultaneously passing a budget that takes away the resources she needs to do her job.

It is chutzpah as well for the Republicans on this subcommittee to complain that FDA is not doing enough about food safety...

The result would be the reverse of what the American people want: fewer inspections and more adulterated and dangerous food and drugs.

FDA's ability to protect the American public is an important topic for oversight.

I sincerely hope my colleagues on both sides of the aisle will work with me to provide FDA with the authority it needs to improve the safety of imports coming across our border.

I think it is very narrow and mean-spirited to try to deny us an opportunity to hear witnesses that we think could add to the hearing.

this is the fourth oversight hearing, and three out of the four, we have been denied minority witnesses.

America's role in the world requires engagement.

We have worked in a kind of perfectly bipartisan way on this Commission because we all believe in it.

This is a unique Commission, I think. And it is very closely targeted.

There is nothing that is more fulfilling and rewarding in the work that we do as Members of the United States Congress than to see the kind of benefit that we have been able to put into place here.

It offers them political legitimacy, in a sense, because often what we are doing is giving an additional dimension to reform efforts.

We are taking on a very specific set of countries.

To reduce the deficit we should reduce the spending and increase the revenue with a tax increase.

I am frustrated by the lack of prosecution.

I really appreciate Ms. Mithal's recommendation that we carry cash.